Serious Side Effects: Pancreatitis : Inflammation of the pancreas, rare but serious Gallbladder Disease: Includes gallstones or gallbladder inflammation Achieve Your Weight Loss Goals with Compounded Semaglutide Individual Results Vary : Weight loss outcomes depend on diet, exercise, and your unique health profile
It is not recommended for use in breast feeding women
2.3 Experimental protocol and induction of hepatotoxicity After an adaptation period of 2 weeks
Mounjaro is not approved for PCOS
The following are contraindications for this treatment: Family history of thyroid cancer Allergy to any active ingredient Certain medicationsdiscuss any medications you are on during your consultation Patient with Multiple Endocrine Neoplastic Syndrome Type 2 (MENS 2) If you have any of the following, inform your consultant about it/them: Gastroparesis Pancreatitis Visual problems Kidney issues Pregnancy and breastfeeding Hypoglycemia Adults are typically considered for medical weight management with semaglutide-class therapy when their BMI is 30, or 27 with weight-related comorbidities (Type 2 diabetes, hypertension, dyslipidemia, sleep apnea, established cardiovascular disease)